DUBLIN, Dec. 1, 2023 /PRNewswire/ — The “DUPIXENT Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. DUPIXENT’s potential as a game-changer extends further with its invention through Regeneron’s proprietary VelocImmune technology. This…